We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NAUT market cap is 124.78M. The company's latest EPS is USD -0.4414 and P/E is -1.77.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.61M | -20.79M | -19.1M | -19.98M | -18.84M |
| Net Income | -18.73M | -18.01M | -16.45M | -17.59M | -16.61M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -576k | -50.5M | -63.62M | -76.15M | -81.48M |
| Net Income | -523k | -50.32M | -57.92M | -63.68M | -70.78M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 288.65M | 272.75M | 259.7M | 242.74M | 227.69M |
| Total Liabilities | 39.16M | 37.47M | 36.27M | 34.01M | 33.26M |
| Total Equity | 249.49M | 235.28M | 223.43M | 208.73M | 194.44M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 150.86M | 398.45M | 350.05M | 305.57M | 242.74M |
| Total Liabilities | 5.62M | 34.87M | 35.13M | 40.21M | 34.01M |
| Total Equity | 5M | 363.58M | 314.92M | 265.35M | 208.73M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -16.27M | -31.72M | -44.84M | -59.15M | -13.94M |
| Investing | 22.35M | 36.65M | 29.14M | 66.25M | 19.51M |
| Financing | 245k | 564k | 704k | 1.14M | 18k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -549k | -39.24M | -45.81M | -51.71M | -59.15M |
| Investing | -149.5M | -138.96M | -25.74M | -43.74M | 66.25M |
| Financing | 151.05M | 327.45M | 562k | 368k | 1.14M |
| Market Cap | 124.78M |
| Price to Earnings Ratio | -1.77 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.52 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 160.34M |
| Average Volume (1 week) | 117.08k |
| Average Volume (1 Month) | 602.2k |
| 52 Week Change | -66.46% |
| 52 Week High | 3.09 |
| 52 Week Low | 0.66 |
| Spread (Intraday) | 0.14 (16.28%) |
| Company Name | Nautilus Biotechnology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.nautilus.bio |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
